CHaRRM-CN for Opioid Use Disorder

Phase-Based Progress Estimates
Cherokee Nation Health Services, Tahlequah, OKOpioid Use DisorderCHaRRM-CN - Other
All Sexes
What conditions do you have?

Study Summary

This trial tests if a program aiming to improve retention in MAT, reduce substance-related harm and increase cultural connectedness is effective.

Eligible Conditions
  • Opioid Use Disorder

Treatment Effectiveness

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: Baseline, month 1, month 3, month 6

Month 6
Health-related quality of life (HR-QoL)
Illicit Opioid Use
Native enculturation
Native self-reliance
Substance-related harm
Baseline, month 6
ED visits
Month 6
MAT retention

Trial Safety

Trial Design

2 Treatment Groups

Treatment as Usual (TAU)
1 of 2
1 of 2

Active Control

Experimental Treatment

160 Total Participants · 2 Treatment Groups

Primary Treatment: CHaRRM-CN · No Placebo Group · N/A

Experimental Group · 1 Intervention: CHaRRM-CN · Intervention Types: Other
Treatment as Usual (TAU)
ActiveComparator Group · 1 Intervention: Treatment as usual (TAU) · Intervention Types: Other

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, month 1, month 3, month 6

Who is running the clinical trial?

Washington State UniversityLead Sponsor
87 Previous Clinical Trials
55,553 Total Patients Enrolled
Cherokee Nation Health ServicesUNKNOWN
1 Previous Clinical Trials
200 Total Patients Enrolled
University of WashingtonOTHER
1,611 Previous Clinical Trials
1,572,782 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,270 Previous Clinical Trials
2,032,299 Total Patients Enrolled
Mark Taylor, MSPrincipal InvestigatorCherokee Nation Health Services
Susan E Collins, PhDPrincipal InvestigatorWashington State University
2 Previous Clinical Trials
402 Total Patients Enrolled
Lonnie A Nelson, PhDPrincipal InvestigatorWashington State University
2 Previous Clinical Trials
991 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 3 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:

Frequently Asked Questions

Are individuals still able to join this clinical experiment?

"Affirmative. records demonstrate that this research project, which was first published on January 17th 2023, is currently enrolling volunteers. Approximately 160 individuals are sought to participate in the trial at a single location." - Anonymous Online Contributor

Unverified Answer

What is the current enrollment of participants in this clinical investigation?

"Affirmative. According to, the recruitment phase of this medical experiment began on January 17th 2023 and concluded February 15th 2023. 160 patients are required between 1 facility for its completion." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.